|Bid||5.00 x 1100|
|Ask||9.99 x 1400|
|Day's Range||9.35 - 11.00|
|52 Week Range||8.88 - 25.80|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Investors need to pay close attention to Athira Pharma (ATHA) stock based on the movements in the options market lately.
A look at the shareholders of Athira Pharma, Inc. ( NASDAQ:ATHA ) can tell us which group is most powerful. Generally...
Leen Kawas, who resigned from her position as CEO and president of Athira, had been on temporary leave since June.